Trials / Terminated
TerminatedNCT02885324
Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 2 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
This pilot will study the feasibility and exploratory efficacy of using Cabozantinib for recurrent or refractory central nervous system tumors for which there are no curative options. Patients will also be followed for safety, time to progression, event free survival and overall survival
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cabozantinib | Subjects will receive Cabozantinib |
Timeline
- Start date
- 2017-05-18
- Primary completion
- 2020-08-25
- Completion
- 2020-08-25
- First posted
- 2016-08-31
- Last updated
- 2022-10-06
- Results posted
- 2022-08-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02885324. Inclusion in this directory is not an endorsement.